Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$... (and government agencies to deliver world...)

HOME >> MEDICINE >> NEWS

Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$17 Billion

Date:6/18/2008

and government agencies to deliver world-class training programs and promote best practices. SAGE is one of the first industry-wide training initiatives in the region and complements company specific training centers in Singapore. SAGE also provides basic training for people who are interested to join the industry.

Mr. Angoh said: "Our employees in Singapore are extremely motivated, productive and driven to deliver the best standards in quality control and assurance. Singapore also offers a pool of highly qualified graduates trained in local tertiary institutions that emphasize science and engineering."

Sophisticated Infrastructure

Located on the western tip of Singapore, Tuas Biomedical Park (TBP), a 890 acres stretch of ready-prepared and specifically-zoned land, presents a conducive environment for pharmaceutical and biologics manufacturing.

TBP is currently home to leading pharmaceutical, biotechnology and medical technology companies such as Abbott, Alcon, CIBA Vision, Genentech, GlaxoSmithKline Biologicals, Lonza, Merck Sharp & Dohme, Novartis, Pfizer and Wyeth. These companies have collectively invested US$4 billion to set up manufacturing facilities in TBP. Equipped with established infrastructure such as roads, drainage systems, power, water supply, and telecommunication lines, TBP continues to attract leading biomedical sciences companies to set up manufacturing facilities here. These companies can also leverage on third- party utilities and services such as steam, natural gas, chilled water and waste treatment.

In addition, TBP offers environmentally-friendly utility solutions that contribute to greater energy efficiency and cost savings. Tuas Power, a leading power company in Singapore that promotes clean technologies, has set up Trigeneration capabilities to produce three types of utilities, electricity, steam and chilled water, from a single integrated system. Tuas Power is currently developing state-of-the-art trigen
'/>"/>

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Lab-on-chip testing for bird flu developed by Singapore scientists
2. Hill-Rom Announces Singapore Will Be Site for Asia-Pacific Innovation Center
3. Three Hospitals in Singapore Join Companion Global Healthcare Network
4. Wyeth to Expand State-of-the-Art Nutritional Manufacturing Facility in Singapore
5. Hospital Care in Singapore Now Available to American Patients at Pre-Negotiated, In-Network Rates Far Lower than Comparable Services in the U.S.
6. Marian Koshland Science Museum forms partnership with Science Center Singapore
7. Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd.
8. Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translational Research
9. Health Information Exchange Consensus Conference Reinforces Key Role of State-Level Entities
10. Pilot study reinforces use of portable anteroom HEPA filtration
11. AMA Reinforces Commitment to Cover the Uninsured at Annual Meeting

Post Your Comments:

Singapore Reinforces Position as a Global Site for Pharma & Biotech; Biomedical Manufacturing Output Quadruples to Reach US$...(and government agencies to deliver world...),Health